Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
No-code experiment design and lab automation platform for design-of-experiments workflows in life sciences R&D.
Synthace, founded in 2011 and headquartered in London, United Kingdom, provides a cloud platform for designing multifactorial experiments, driving lab automation equipment, and capturing structured experimental data — supporting design-of-experiments (DOE) approaches in biology R&D. The company raised a $35M Series C in November 2021. It does not publish a public security certification page, so request documentation during evaluation.
36% — Limited coverage. Coverage score — how completely Atlas documents Synthace across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, Drug Discovery, R&D Leadership, Data Engineer / Architect
Data & AI Infrastructure
Series C, Founded 2011
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?